Cargando…

The Aldose Reductase Inhibitor Epalrestat Maintains Blood–Brain Barrier Integrity by Enhancing Endothelial Cell Function during Cerebral Ischemia

Excessive activation of aldose reductase (AR) in the brain is a risk factor for aggravating cerebral ischemia injury. Epalrestat is the only AR inhibitor with proven safety and efficacy, which is used in the clinical treatment of diabetic neuropathy. However, the molecular mechanisms underlying the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tongshuai, Wu, Jinrong, Yao, Xinmin, Zhang, Yao, Wang, Yue, Han, Yang, Wu, Yun, Xu, Zhenyu, Lan, Jing, Han, Siyu, Zou, Haifeng, Sun, Qixu, Wang, Dandan, Zhang, Jingyu, Wang, Guangyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224835/ https://www.ncbi.nlm.nih.gov/pubmed/36940077 http://dx.doi.org/10.1007/s12035-023-03304-z

Ejemplares similares

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Amelioration of Bleomycin-induced Pulmonary Fibrosis of Rats by an Aldose Reductase Inhibitor, Epalrestat
por: Li, Xianwei, et al.
Publicado: (2015)

Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats
por: Yang, Bai-Bing, et al.
Publicado: (2018)

Correction: Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats
por: Yang, Bai-Bing, et al.
Publicado: (2019)

Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury
por: El Gamal, Heba, et al.
Publicado: (2017)

Corrigendum to “Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury”
por: El Gamal, Heba, et al.
Publicado: (2019)

Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase
por: Shi, Wei, et al.
Publicado: (2023)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
por: Iyer, Sangeetha, et al.
Publicado: (2019)

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat
por: Hotta, N, et al.
Publicado: (2008)

The Inhibition of Aldose Reductase Accelerates Liver Regeneration through Regulating Energy Metabolism
por: Li, Chang Xian, et al.
Publicado: (2020)

Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia
por: Son, Ni-Huiping, et al.
Publicado: (2012)

Screening and Isolating Major Aldose Reductase Inhibitors from the Seeds of Evening Primrose (Oenothera biennis)
por: Wang, Zhiqiang, et al.
Publicado: (2019)

Structure of aldose reductase from Giardia lamblia
por: Ferrell, M., et al.
Publicado: (2011)

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy
por: Hotta, N, et al.
Publicado: (2012)

Physiological and Pathological Roles of Aldose Reductase
por: Singh, Mahavir, et al.
Publicado: (2021)

In Search of Differential Inhibitors of Aldose Reductase
por: Balestri, Francesco, et al.
Publicado: (2022)

Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
por: Tang, Wai Ho, et al.
Publicado: (2012)

Inhibition of Aldose Reductase by Gentiana lutea Extracts
por: Akileshwari, Chandrasekhar, et al.
Publicado: (2012)

Aldose Reductase Differential Inhibitors in Green Tea
por: Balestri, Francesco, et al.
Publicado: (2020)

Human aldose reductase unfolds through an intermediate
por: Sekhon, Gurprit, et al.
Publicado: (2019)

Molecular docking analysis of flavonoids with aldose reductase
por: Kannayiram, Kasthuri, et al.
Publicado: (2022)

The Role of Aldose Reductase in Beta-Amyloid-Induced Microglia Activation
por: Huang, Yu-Kai, et al.
Publicado: (2022)

Aldose reductase mediates endothelial cell dysfunction induced by high uric acid concentrations
por: Huang, Zhiyong, et al.
Publicado: (2017)

Aldose Reductase Gene Polymorphisms and Diabetic Retinopathy Susceptibility
por: Abhary, Sotoodeh, et al.
Publicado: (2010)

Stereoselectivity of Aldose Reductase in the Reduction of Glutathionyl-Hydroxynonanal Adduct
por: Balestri, Francesco, et al.
Publicado: (2019)

Tracer metabolomics reveals the role of aldose reductase in glycosylation
por: Radenkovic, Silvia, et al.
Publicado: (2023)

N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model
por: Wang, Linna, et al.
Publicado: (2023)

Excess salt exacerbates blood-brain barrier disruption via a p38/MAPK/SGK1-dependent pathway in permanent cerebral ischemia
por: Zhang, Tongshuai, et al.
Publicado: (2015)

In vitro antidiabetic effects of selected fruits and vegetables against glycosidase and aldose reductase
por: Wu, Tong, et al.
Publicado: (2015)

Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy
por: Reddy, G. Bhanuprakash, et al.
Publicado: (2008)

Aldose Reductase Inhibition Prevents Metaplasia of Airway Epithelial Cells
por: Yadav, Umesh C. S., et al.
Publicado: (2010)

Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts
por: Karasu, Çimen, et al.
Publicado: (2012)

A New Approach to Control the Enigmatic Activity of Aldose Reductase
por: Del-Corso, Antonella, et al.
Publicado: (2013)

Inhibitory activities of selected Kampo formulations on human aldose reductase
por: Onoda, Toshihisa, et al.
Publicado: (2014)

Characterization of WY 14,643 and its Complex with Aldose Reductase
por: Sawaya, Michael R., et al.
Publicado: (2016)

Soyasaponins from Zolfino bean as aldose reductase differential inhibitors
por: Balestri, Francesco, et al.
Publicado: (2018)

General toxicity assessment of the novel aldose reductase inhibitor cemtirestat
por: PRNOVÁ, Marta ŠOLTÉSOVÁ, et al.
Publicado: (2019)

Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice
por: Liu, H., et al.
Publicado: (2011)

Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion
por: Thiagarajan, Devi, et al.
Publicado: (2017)

Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice
por: Yadav, Umesh C. S., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_v1b15l407n06ah0c7fmorgdl39